Title: Which Types of Alcohol-Use Disorder Will Asialotransferrin Detect?
Abstract: Approximately 20% of patients seen in clinical practice have an underlying alcohol-use disorder (1). In the last 20 years, specialist work on alcohol misuse has focused mainly on diagnosis at the dependence stage. However, there is also a need to direct attention to alcohol abuse, the long, little-studied, and insufficiently treated disease during which processes damaging to health and social functioning are initiated. Recently, Legros et al. (2) concluded that as a biomarker, asialotransferrin offered the best differentiation between moderate and abusive alcohol consumption.
From a methodologic point of view, clinical investigations concerning biomarkers of alcohol abuse or …